Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Peter J. Vanveldhuizen"'
Autor:
Sushanta K. Banerjee, Peter J. Vanveldhuizen, Gibanananda Ray, Monami Majumder, Gopal Dhar, Inamul Haque, Smita Mehta, Kakali Dhar, Snigdha Banerjee, Suman Kambhampati
The purpose of this study was to evaluate whether 2-methoxyestradiol (2-ME2), a promising anticancer agent, modulates Barrett's esophageal adenocarcinoma (BEAC) cell growth and behavior through a cellular pathway involving β-catenin in partnership w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f1913ed0dd3144eed381a6c6e56d42
https://doi.org/10.1158/1535-7163.c.6531581
https://doi.org/10.1158/1535-7163.c.6531581
Autor:
Sushanta K. Banerjee, Peter J. Vanveldhuizen, Gibanananda Ray, Monami Majumder, Gopal Dhar, Inamul Haque, Smita Mehta, Kakali Dhar, Snigdha Banerjee, Suman Kambhampati
Supplementary Data from 2-Methoxyestradiol Inhibits Barrett's Esophageal Adenocarcinoma Growth and Differentiation through Differential Regulation of the β-Catenin–E-Cadherin Axis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0da5be8c1198f5d9c4fdb5a9aaa91592
https://doi.org/10.1158/1535-7163.22484777.v1
https://doi.org/10.1158/1535-7163.22484777.v1
Autor:
Sushanta K. Banerjee, Peter J. VanVeldhuizen, Matthew S. Mayo, Ossama Tawfik, Kakali Dhar, Snigdha Banerjee, Gopal Dhar
Supplementary Figure 1 from Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122d068de1b051303111966aa1926bca
https://doi.org/10.1158/0008-5472.22371354.v1
https://doi.org/10.1158/0008-5472.22371354.v1
Autor:
Sushanta K. Banerjee, Peter J. VanVeldhuizen, Matthew S. Mayo, Ossama Tawfik, Kakali Dhar, Snigdha Banerjee, Gopal Dhar
CCN5/WISP-2 is overexpressed in noninvasive breast cancer cells and tissue samples, whereas its expression is minimal or undetected in invasive conditions. CCN5/WISP-2 has been considered as an antiinvasive gene because CCN5/WISP-2 silencing augments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b155b152fd2ed8ecbb58410f74c7c3a7
https://doi.org/10.1158/0008-5472.c.6496761
https://doi.org/10.1158/0008-5472.c.6496761
Autor:
Sushanta K. Banerjee, Peter J. VanVeldhuizen, Matthew S. Mayo, Ossama Tawfik, Kakali Dhar, Snigdha Banerjee, Gopal Dhar
Supplementary Figure 1 Legend from Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8049185a81f0441d266bccffd9e8652a
https://doi.org/10.1158/0008-5472.22371357
https://doi.org/10.1158/0008-5472.22371357
Publikováno v:
Current Cancer Therapy Reviews. 8:264-270
Autor:
Peter J. Vanveldhuizen, Seema Dubey, J. Brantley Thrasher, Dev Karan, Ossama Tawfik, Jeffrey M. Holzbeierlein
Publikováno v:
Oncology Letters. 3:1166-1170
Macrophage inhibitory cytokine-1 (MIC-1), also known as prostate-derived factor (PDF), is a molecule of the TGF-β superfamily and has been associated with the progression of various types of diseases including prostate cancer. Initially identified f
Autor:
Paul R. Womble, Jeffrey M. Holzbeierlein, J. Brantley Thrasher, Greg A. Reed, Alan A. Nisbet, Peter J. VanVeldhuizen
Publikováno v:
Journal of Urology. 186:882-888
Patients with high risk prostate cancer (prostate specific antigen greater than 20 ng/ml, Gleason score greater than 7, or clinical stage T2b or greater) have been shown to have a 30% to 40% biochemical recurrence rate after definitive local therapy.
Autor:
Peter J. Vanveldhuizen, Gopal Dhar, Kakali Dhar, Sushanta K. Banerjee, Gibanananda Ray, Inamul Haque, Smita Mehta, Snigdha Banerjee, Suman Kambhampati, Monami Majumder
Publikováno v:
Molecular Cancer Therapeutics. 9:523-534
The purpose of this study was to evaluate whether 2-methoxyestradiol (2-ME2), a promising anticancer agent, modulates Barrett's esophageal adenocarcinoma (BEAC) cell growth and behavior through a cellular pathway involving β-catenin in partnership w
Autor:
Jeremy A Freeman, Michael S. Gordon, David I. Quinn, Peter J. Vanveldhuizen, Thomas W. Flaig, Brendan D. Curti, Rachel Bittner, Igor Puzanov, John A. Thompson, Naomi Hunder, Kelly Byrnes-Blake, Shailender Bhatia, Wilson H. Miller, Elisabeth I. Heath, Marc S. Ernstoff, Sonia Souza
Publikováno v:
Journal for Immunotherapy of Cancer
Background Despite the positive impact of targeted therapies on metastatic renal cell carcinoma (mRCC), durable responses are infrequent and an unmet need exists for novel therapies with distinct mechanisms of action. We investigated the combination